First global malaria map in decades shows reduced risk

About 35 percent of the world’s population is at risk of contracting deadly malaria, but many people are at a lower risk than previously thought, raising hope that the disease could be seriously reduced or eliminated in parts of the world.

So concludes a group of researchers, including a scientist in the University of Florida Emerging Pathogens Institute, who spent three years producing the first spatial map of global malaria risk in four decades.

The Malaria Atlas Project’s findings appear today in the online edition of the open-access medical journal, PLoS Medicine.

The Malaria Atlas Project, or MAP, found that 2.37 billion people were at risk of contracting malaria from Plasmodium faciparum, the most deadly malaria parasite for humans transmitted through the bites of infected Anopheles mosquitoes. Of that number, about 1 billion people live under a much lower risk of infection than was assumed under the previous historical maps. The lower than expected risk extends across Central and South America, Asia and even parts of Africa, the continent where malaria kills the vast majority of its victims and where risk has historically been classified as universally high.

“This gives some hope of pursuing malaria elimination because the prevalence isn’t as universally high as many people suppose,” said David Smith, a UF associate professor of zoology and a co-author of the paper. “It’s reasonable to think we can reduce or interrupt transmission in many places, but the prospects for success will improve if we make plans that are based on good information about malaria’s distribution.”

The MAP effort, a collaboration between Oxford University and the Kenyan Medical Research Institute, compiled information from national health statistics, tourist travel advisories, climate, mosquito vectors and surveys of malaria infection in nearly 5,000 communities and 87 countries. The project also incorporated information about how climatic conditions affect mosquito life cycles, and thus the likelihood of active transmission.

“One of my contributions was to help standardize prevalence estimates,” Smith said.

The new map is important in part because it offers hope that malaria could be eliminated in certain areas using currently available tools, such as bed nets treated with insecticide that kills mosquitoes, the researchers said. It will also help donors and international agencies target investments in control measures where they are most likely to achieve the biggest gains.

More than 500 million cases of malaria are reported annually. Of those afflicted, about one million die; 80 percent of them are children in sub-Saharan Africa.

“Making data and maps more accessible on the worldwide web is a large part of the MAP’s philosophy of getting the science accessed, critiqued and used by a much wider range of users,” said the lead author of the paper, Carlos Guerra, of the University of Oxford.

Source: University of Florida

Related stories:

Global maps created to show malaria hotspots
Global maps are being created that will define, for the first time in over 40 years, the distribution of malaria risk worldwide. The atlas will help those involved in malaria control.
15 human genomes each week
The Wellcome Trust Sanger Institute has sequenced the equivalent of 300 human genomes in just over six months. The Institute has just reached the staggering total of 1,000,000,000,000 letters of genetic code that will be read by researchers worldwide, helping them to understand the role of genes in health and disease. Scientists will be able to answer questions unthinkable even a few years ago and human medical genetics will be transformed.
Genetically modified mosquitoes may combat malaria
(AP) -- In a cramped, humid laboratory in London, mosquitoes swarming in stacked, net-covered cages are being scrutinized for keys to controlling malaria.
Better treatments for malaria in pregnancy are needed
Malaria in pregnancy threatens the life of both mother and child, and yet there has been very little research on how best to treat it, say a team of malaria experts in this week's PLoS Medicine.
With annual deaths from malaria on the rise: Scientists ask 'where is all the money going?'
A new study in the April issue of the American Journal of Tropical Medicine and Hygiene, asks the question "With more than $220 million dollars dedicated to malaria treatment and prevention, why is the annual mortality rate from malaria on the rise?"
Discovery could lead to attack on mosquito-borne disease
Cornell researchers have identified a mating mechanism that possibly could be adapted to prevent female mosquitoes from spreading the viruses that cause dengue fever, second only to malaria as the most virulent mosquito-borne disease in the tropical world.
Newly developed anti-malarial medicine treats toxoplasmosis
A new drug that will soon enter clinical trials for treatment of malaria also appears to be 10 times more effective than the key medicine in the current gold-standard treatment for toxoplasmosis, a disease caused by a related parasite that infects nearly one-third of all humans—more than two billion people worldwide.
Swiss researchers develop antibody test
ETH Zurich professor Peter Seeberger has been working on a sugar-based malaria vaccine for years. The new test takes him one important step closer to his goal. The malaria pathogen plasmodium falciparum carries poisonous sugar molecules – called GPIs for short – on its surface that are able to be individually identified. Professor See-berger’s research team is now developing a new method that demonstrates that the malaria pathogen’s toxic sugar molecules trigger a specific immune reaction in adults.

News discussion:

Medicine & Health news